| Value | ₹46.57 Cr |
|---|
BSE filing, BSE: 544529. Summary written from the filing by ALFA Finder's alert engine.
Aptus Pharma Ltd: key numbers
- Share price
- ₹476.00
- Market cap
- ₹816.3 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 176.7×Sector 41.3×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aptus Pharma Ltd
All →Aptus Pharma Preferential Issue
Aptus Pharma got BSE in-principle approval for a preferential issue of 15,99,270 shares at a minimum Rs. 280 each. The issue is worth about Rs. 44.78 Crore.
- Value
- ₹44.78 Cr
Aptus Pharma Investor Presentation: Key Takeaways
H1 FY27 revenue ₹48.92 Cr, EBITDA ₹7.68 Cr (15.7% margin), PAT ₹5.07 Cr; revenue exceeds full FY26 (₹46.57 Cr). Trading-heavy model with rising receivables and negative operating cash flow.
Aptus Pharma H1 FY27 Results: Net Profit ₹5.1 Cr, Up 200.0% YoY
Aptus Pharma Ltd reported revenue from operations of ₹48.9 Cr (+239.6% YoY) and net profit of ₹5.1 Cr (+200.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.1 Cr · +200.0% YoY
Aptus Pharma Other Announcement
Aptus Pharma Limited submitted the Regulation 74(5) compliance certificate for the quarter and half-year ended 30th September 2026, as received from its registrar.
Aptus Pharma Annual General Meeting
Aptus Pharma Ltd issued a corrigendum to its 16th AGM notice regarding inadvertent errors in the explanatory statement for item no. 3.
Aptus Pharma Fund Raise of ₹44.88 Cr
Aptus Pharma Limited's Board has approved raising ₹44.88 Crore through a preferential equity issue. Funds will support manufacturing capacity expansion, working capital, and Pan-India growth initiatives.
- Value
- ₹44.88 Cr
- Execution
- 36 months
Other financial results announcements
All →Gaja Alternative Asset Management Q2 FY27 Results: Net Profit ₹64.7 Cr, Up 54.0% YoY
Gaja Alternative Asset Management Ltd reported revenue from operations of ₹38.4 Cr (-43.9% YoY) and net profit of ₹64.7 Cr (+54.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹64.7 Cr · +54.0% YoY
Garuda Construction and Engineering Q2 FY27 Results: Net Profit ₹40.6 Cr, Up 49.8% YoY
Garuda Construction and Engineering Ltd reported revenue from operations of ₹171.6 Cr (+47.3% YoY) and net profit of ₹40.6 Cr (+49.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹40.6 Cr · +49.8% YoY
Belding India Q2 FY27 Results: Net Loss of ₹5.6 Cr
Belding India Ltd reported revenue from operations of ₹6.6 Cr and a net loss of ₹5.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹5.6 Cr
Lupin Q2 FY27 Results: Net Profit ₹1,155 Cr, Down 22.2% YoY
Lupin Ltd reported revenue from operations of ₹7,827 Cr (+11.1% YoY) and net profit of ₹1,155 Cr (-22.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,155 Cr · -22.2% YoY
HEG Advanced Materials Q2 FY27 Results: Net Profit ₹306.1 Cr, Up 58.4% YoY
HEG Advanced Materials Ltd reported revenue from operations of ₹429.9 Cr (+144.4% YoY) and net profit of ₹306.1 Cr (+58.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹306.1 Cr · +58.4% YoY
NDR InvIT Trust Q2 FY27 Results: Net Profit ₹34 Cr, Down 7.1% YoY
NDR InvIT Trust reported revenue from operations of ₹132.2 Cr (+27.6% YoY) and net profit of ₹34 Cr (-7.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹34 Cr · -7.1% YoY